These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 18199989)

  • 41. Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea.
    Bayes-Genis A; Lloyd-Jones DM; van Kimmenade RR; Lainchbury JG; Richards AM; Ordoñez-Llanos J; Santaló M; Pinto YM; Januzzi JL
    Arch Intern Med; 2007 Feb; 167(4):400-7. PubMed ID: 17325303
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure.
    Dieplinger B; Gegenhuber A; Struck J; Poelz W; Langsteger W; Haltmayer M; Mueller T
    Clin Chim Acta; 2009 Feb; 400(1-2):91-6. PubMed ID: 19000665
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. N-terminal pro-brain natriuretic peptide as a diagnostic marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium-channel blockers.
    Allanore Y; Borderie D; Meune C; Cabanes L; Weber S; Ekindjian OG; Kahan A
    Arthritis Rheum; 2003 Dec; 48(12):3503-8. PubMed ID: 14674001
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amino-terminal pro-brain natriuretic peptide for the diagnosis of acute heart failure in patients with previous obstructive airway disease.
    Tung RH; Camargo CA; Krauser D; Anwaruddin S; Baggish A; Chen A; Januzzi JL
    Ann Emerg Med; 2006 Jul; 48(1):66-74. PubMed ID: 16781921
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation of B type natriuretic peptides with clinical and echocardiographic parameters in heterogeneous population of patients with symptoms suggestive of heart failure.
    Piechota WN; Piechota WT; Bejm J; Wierzbowski R; Michałkiewicz D
    Adv Med Sci; 2006; 51():164-7. PubMed ID: 17357300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction.
    Löwbeer C; Gustafsson SA; Seeberger A; Bouvier F; Hulting J
    Scand J Clin Lab Invest; 2004; 64(7):667-76. PubMed ID: 15513324
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic accuracy of plasma brain natriuretic peptide and aminoterminal-proBNP in mild heart failure depends on assay and introduction of therapy.
    Mikkelsen KV; Bie P; Møller JE; Ryde H; Videbaek L; Haghfelt T
    Scand J Clin Lab Invest; 2005; 65(8):633-47. PubMed ID: 16319038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NT-proBNP concentrations indicate cardiac disease in pediatric patients.
    Geiger R; Hammerer-Lercher A; Url C; Schweigmann U; Puschendorf B; Sommer R; Stein JI; Mair J
    Int J Cardiol; 2007 Dec; 123(1):63-5. PubMed ID: 17289184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms.
    Januzzi JL; Chen-Tournoux AA; Moe G
    Am J Cardiol; 2008 Feb; 101(3A):29-38. PubMed ID: 18243855
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.
    Zdrenghea D; Pop D; Ilea M; Bodisz G; Mălai A; Zdrenghea M
    Rom J Intern Med; 2009; 47(1):35-40. PubMed ID: 19886067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.
    Weber M; Bazzino O; Navarro Estrada JL; Fuselli JJ; Botto F; Perez de Arenaza D; Möllmann H; Nef HN; Elsässer A; Hamm CW
    J Am Coll Cardiol; 2008 Mar; 51(12):1188-95. PubMed ID: 18355657
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Takotsubo cardiomyopathy has a unique cardiac biomarker profile: NT-proBNP/myoglobin and NT-proBNP/troponin T ratios for the differential diagnosis of acute coronary syndromes and stress induced cardiomyopathy.
    Fröhlich GM; Schoch B; Schmid F; Keller P; Sudano I; Lüscher TF; Noll G; Ruschitzka F; Enseleit F
    Int J Cardiol; 2012 Feb; 154(3):328-32. PubMed ID: 22044675
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults.
    Dodos F; Halbsguth T; Erdmann E; Hoppe UC
    Clin Res Cardiol; 2008 May; 97(5):318-26. PubMed ID: 18193371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD.
    Chang CL; Robinson SC; Mills GD; Sullivan GD; Karalus NC; McLachlan JD; Hancox RJ
    Thorax; 2011 Sep; 66(9):764-8. PubMed ID: 21474497
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monitoring of the very early changes of left ventricular diastolic function in patients with acute leukemia treated with anthracyclines.
    Pudil R; Horacek JM; Strasova A; Jebavy L; Vojacek J
    Exp Oncol; 2008 Jun; 30(2):160-2. PubMed ID: 18566583
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: a longitudinal study.
    Jacobs LH; van de Kerkhof JJ; Mingels AM; Passos VL; Kleijnen VW; Mazairac AH; van der Sande FM; Wodzig WK; Konings CJ; Leunissen KM; van Dieijen-Visser MP; Kooman JP
    Nephrol Dial Transplant; 2010 Jan; 25(1):243-8. PubMed ID: 19692417
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term cardiac effects of treatment for childhood leukemia.
    Urbanova D; Urban L; Simkova I; Danova K; Mikuskova E; Mladosievicova B
    Neoplasma; 2010; 57(2):179-83. PubMed ID: 20099983
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined measurement of N-terminal pro-B-type natriuretic peptide and highly sensitive cardiac troponin T for diagnosis and monitoring of heart injury in chronic Chagas' disease.
    Munoz Saravia SG; Haberland A; Bartel S; Araujo R; Valda G; Reynaga DD; Ramirez ID; Borges AC; Wallukat G; Ziebig R; Schimke I
    Clin Biochem; 2013 Oct; 46(15):1615-8. PubMed ID: 23810852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.